If You Used Johnson’s Baby Powder for Years and Were Diagnosed With Mesothelioma, Read This Before You Talk to Anyone
You are reading this at a hour when nobody should have to be awake. Maybe the diagnosis came this week. Maybe it came months ago and you have been searching in the margins of your life, between appointments, between the words doctors use when they are trying not to frighten you. Maybe someone you love is already gone, and you are sitting at a kitchen table with a death certificate and a bottle of baby powder that you cannot bring yourself to throw away.
Here is what we know, and what we will tell you straight: A product you trusted — that you used on yourself, on your children, in some cases on your grandchildren — was contaminated with asbestos for decades. The company that made it knew. Internal corporate records and expert testimony proved that to a Los Angeles jury. That jury ordered Johnson & Johnson to pay $32 million to the family of a woman who used its baby powder daily for more than fifty years and died of mesothelioma.
We are Attorney911 — The Manginello Law Firm. We take toxic tort cases and wrongful death claims in California, working with local counsel where the rules require it. This page is legal information, not legal advice. Contacting the firm is free and confidential. But what follows is the full picture — the law, the medicine, the evidence, the money, and the clock — because the person reading this at 2 a.m. deserves the same explanation we would give across a kitchen table in the morning.
The $32 Million Verdict — What a Los Angeles Jury Decided
A Los Angeles jury heard the case of a woman who used Johnson’s Baby Powder daily for more than fifty years — applying it to herself and her children regularly. Her husband used it too. She was diagnosed with pleural mesothelioma in 2023. She filed a personal injury lawsuit. She died in 2024. Her three children continued the case as a wrongful death lawsuit, and the jury returned a $32 million verdict against Johnson & Johnson.
The family’s legal team presented internal corporate records and expert testimony showing that J&J knew about the risks of asbestos contamination in its talc products for decades but did not warn consumers. They showed the jury that J&J had internal data highlighting asbestos contamination at its mining and processing sites — data the company never acted on and never reported to the FDA.
J&J defended the case by arguing that the mesothelioma came from somewhere else: environmental asbestos exposure, other cosmetic brands, or the husband’s automotive work. The jury rejected every one of those arguments and placed full responsibility on J&J.
J&J has announced it will appeal the verdict. That appeal will take time, and the verdict amount may change — but the jury’s finding of full responsibility, built on decades of internal corporate documents, is the foundation everything else rests on.
This was not an isolated result. It is part of a cascade of verdicts that began after Johnson & Johnson abandoned its third attempt to push all talc claims into bankruptcy — a strategy that froze many cases for years and finally failed in March 2025. Since then, juries across the country have returned verdicts of $966 million in Los Angeles (October 2025), $1.5 billion in Baltimore (December 2025), $65.5 million in Minnesota (December 2025), and a Philadelphia verdict in February 2026 for a woman who used the product for more than forty-five years and died of ovarian cancer. Each of those is a jury verdict, and each is subject to post-trial motions and appeal — we are not telling you these are final, confirmed recoveries. We are telling you that juries are seeing the evidence and siding with families, and the trend is accelerating.
J&J now faces roughly 60,000 remaining talc-related claims in courts across the country. The bankruptcy freeze is over. The cases are moving.
California’s Strict Liability Law — Why the Manufacturer Pays Even Without Proof of Negligence
California is one of the strongest states in the country for a person injured by a defective product. The reason goes back to a landmark California Supreme Court decision that created the modern doctrine of strict products liability — a rule that says a manufacturer is responsible when its product is defective and causes injury, even if the company was not careless.
California strict products liability recognizes three ways a product can be defective. The first is a manufacturing defect — the product departed from its intended design. The second is a design defect — the product was inherently dangerous in the way it was designed. The third is failure to warn — the manufacturer knew or should have known about a danger and failed to warn consumers.
In the talc cases, the primary theories are manufacturing defect and failure to warn. Asbestos cross-contamination of talc during mining and processing rendered the product dangerously defective when it left J&J’s control — the product contained a known carcinogen that should not have been there. And J&J possessed internal data for decades showing that contamination, yet never added asbestos warnings to its product labels or reported its findings to the FDA.
Under California law, the duty to warn of known or reasonably foreseeable dangers is independent of any negligence theory. The manufacturer does not get to say “we were not careless” — if it knew about the danger and said nothing, it is liable. The internal corporate records showing J&J’s decades of knowledge are not just evidence of negligence. They are evidence of a strict duty that was breached.
California also recognizes fraudulent concealment as a distinct basis for liability. When a manufacturer knowingly conceals information about a product’s dangers from consumers and regulators, that concealment is itself a wrong — and it opens the door to punitive damages under a standard that California law sets higher than ordinary negligence.
California’s punitive damages statute authorizes exemplary damages upon a showing of malice, oppression, or fraud by clear and convincing evidence — a standard the Lozano jury’s rejection of every alternative-causation defense suggests was potentially satisfied, particularly given the documented decades of concealed knowledge.
California has no statutory cap on non-economic damages in non-medical-malpractice tort cases. There is no cap on punitive damages. The only federal limit comes from due process ratio analysis — the principle that punitive damages must bear a reasonable relationship to compensatory damages. In cases involving decades of documented corporate concealment, courts have permitted significant punitive awards because the reprehensibility of the conduct is high.
This matters enormously. In a state that caps pain and suffering, the battle shifts to economic losses alone. In California, the full weight of the harm — the pain, the fear, the lost years, the stolen companionship — is compensable. A Los Angeles talc mesothelioma lawyer can pursue the complete measure of damages without a statutory ceiling cutting the value in half.
Los Angeles County Superior Court, where the Lozano trial took place, is one of the most plaintiff-favorable trial venues in the United States for product liability and toxic tort cases. The county has produced multiple nine- and ten-figure verdicts in mass tort litigation. Its jury pool — large, diverse, and historically skeptical of corporate defendants in concealment cases — amplifies the value of documentary evidence showing decades of internal knowledge. This is not a minor factor. The same evidence, in a different courthouse, can produce a different result. In Los Angeles, juries have shown they are willing to listen to the documents and hold corporations accountable.
What Johnson & Johnson Knew — and When They Knew It
The single most powerful set of facts in these cases is not the medicine. It is the paper trail. Lab tests detected asbestos in J&J’s talc products from 1971 through the early 2000s. The company never reported those findings to the U.S. Food and Drug Administration. It did not stop selling talc-based baby powder in the United States until 2020 — and did not stop selling it globally until 2023.
That is a gap of roughly fifty years between the first internal detection of asbestos contamination and the end of global sales. During that half-century, millions of people applied the product to their bodies and their children’s bodies daily — exactly as the label and the marketing encouraged them to do.
Johnson’s Baby Powder was regulated as a cosmetic under the Federal Food, Drug, and Cosmetic Act. The pre-MoCRA cosmetic regulatory regime did not require premarket approval or mandatory adverse-event reporting for cosmetic products. The FDA had authority to investigate cosmetic contaminants and could request recalls — but could not mandate them. This regulatory framework was minimal, and J&J’s decades of concealment took on aggravated liability significance precisely because the regulatory backstop was so thin. When the regulatory system trusts the manufacturer to self-report, the manufacturer’s decision not to report is not a loophole — it is a betrayal of the system itself.
The internal corporate records that the Lozano jury saw — and that juries in subsequent trials have seen — show that J&J had data spanning decades indicating asbestos contamination at its mining and processing sites. The company had the information. It chose not to act on it. It chose not to warn the public. And it chose not to tell the agency that was supposed to be watching.
Johnson & Johnson is not a small company that could not afford to test its product. It is one of the largest pharmaceutical and consumer products corporations in the world. The resources to test, to warn, and to reformulate existed. The decision not to use them was a choice — and the jury in Los Angeles saw it for what it was.
The corporate structure adds another layer. J&J has shuffled its talc liability through a chain of entities — from Johnson & Johnson Consumer Inc., the historical talc seller, to LTL Management LLC, the entity created for the first bankruptcy attempt, to Red River Talc LLC, the vehicle for the third attempt. J&J also spun off its consumer health business as Kenvue Inc., a separate public company, with indemnity arrangements between the two. Naming the right entity — the one that actually owes the duty and holds the resources — is part of the work. The corporate structure is designed to put distance between the liability and the balance sheet. Part of building a talc case is closing that distance.
The Lancet Retraction — A Decades-Old Defense Just Collapsed
In March 2026, something happened that changed the scientific landscape of every pending talc case. The peer-reviewed medical journal The Lancet retracted a nearly fifty-year-old paper that defense attorneys had long used to argue cosmetic talc does not cause cancer.
Public health historians showed that the paper’s author — a J&J consultant — had shared an advance draft of the paper with the company and revised it based on J&J’s feedback before publication. The author never disclosed that relationship.
The Lancet called that undisclosed relationship a “clear breach of publishing ethics.”
This is not a minor academic dispute. For decades, J&J’s defense attorneys cited this paper as independent scientific evidence that cosmetic talc does not cause cancer. It was one of the primary pillars of the general-causation defense — the argument that the scientific literature does not support a link between talc and mesothelioma. Now that pillar has been pulled. The paper was not independent. It was influenced by the very company whose product it was defending. And the journal that published it has formally retracted it.
The retraction matters in two ways. First, it destroys one of the defense’s most-cited scientific sources. J&J can no longer point to this paper as evidence that talc is safe — the paper has been retracted because of the company’s own undisclosed influence on its content. Second, and perhaps more powerfully, the retraction demonstrates a pattern of corporate manipulation of scientific literature. That pattern feeds directly into the fraudulent concealment theory and the punitive damages predicate. A jury that learns the defendant not only hid its own data but also shaped the scientific literature to support its position is a jury that is more likely to find malice, oppression, or fraud by clear and convincing evidence.
Plaintiffs’ attorneys have said they plan to use the retraction directly in upcoming trials. The underlying correspondence between the author and J&J — the draft-sharing and feedback exchanges — requires discovery in pending cases, and witness availability degrades with time. But the retraction itself and the accompanying editorial are permanently available as public record.
If you are facing a talc case, the Lancet retraction is a new weapon. It did not exist when many of the earlier talc cases were tried. It exists now.
The Texas Two-Step Is Over — What That Means for 60,000 Remaining Claims
Johnson & Johnson tried multiple times to end its talc liabilities through a legal strategy known as the “Texas Two-Step.” The maneuver works like this: a company creates a new subsidiary, transfers all of its lawsuit liabilities into that subsidiary, and then has the subsidiary file for bankruptcy. The goal is to force every plaintiff into a bankruptcy proceeding where they must accept whatever settlement the company offers — rather than taking their chances in front of a jury.
A federal judge rejected J&J’s most recent attempt — a proposed $8 billion settlement — in March 2025. That was the third rejection. After the third failure, J&J abandoned the strategy entirely and announced it would litigate each remaining case individually.
This is why the verdicts are mounting so quickly now. For years, the bankruptcy strategy froze many claims in place. Plaintiffs could not get to trial while the bankruptcy court sorted out whether the Texas Two-Step was even lawful. Now that freeze is over. The cases are moving. And the results are coming in.
J&J faces roughly 60,000 remaining talc-related claims in courts across the country. Every verdict — the $32 million in Los Angeles, the $966 million in Los Angeles, the $1.5 billion in Baltimore, the $65.5 million in Minnesota — puts cumulative pressure on J&J’s litigation reserves. The company can no longer try to resolve all claims through a single bankruptcy proceeding. It must fight them one at a time, in courthouses across the country, in front of juries who are now seeing the internal documents, the Lancet retraction, and the pattern of decades of concealment.
For someone reading this page who has been diagnosed with mesothelioma after years of talc use — or who has lost a family member — this means the door is open. The bankruptcy freeze that may have discouraged you or a family member from acting in the past is gone. Your case can proceed.
How Asbestos-Contaminated Talc Causes Mesothelioma
Talc and asbestos are both naturally occurring minerals. They often form closely together in the earth, which creates a high risk of cross-contamination during mining. Talc that is mined from deposits near asbestos ore can contain asbestos fibers — and those fibers are invisible, microscopic, and indestructible.
When a person applies talc-based powder to their body, they release fine particles into the air. Those particles are inhaled. If the talc is contaminated with asbestos, asbestos fibers enter the lungs. The fibers are so small that the body’s natural clearing mechanisms cannot remove them. They lodge in the pleura — the thin membrane that lines the lungs and the chest wall — and they stay there.
The body cannot break down asbestos fibers. Over years and decades, the fibers cause chronic irritation, inflammation, and cellular damage. The immune system tries and fails to clear them. The constant low-grade inflammation eventually damages the DNA of the mesothelial cells that line the pleura, and that damage can lead to cancer — mesothelioma.
Mesothelioma has a latency period of twenty to sixty years. That means symptoms do not appear until decades after the exposure. A person who used baby powder daily in the 1970s and 1980s might not develop mesothelioma until the 2020s or 2030s. This latency is why talc-related mesothelioma cases continue to rise even though J&J stopped selling talc-based baby powder in the U.S. in 2020 and globally in 2023. The exposure happened long ago. The disease is arriving now.
Pleural mesothelioma — the type that develops in the lining of the lungs — is the most common form. It is also the type that the Lozano verdict addressed. The symptoms include shortness of breath, chest pain, persistent cough, and unexplained weight loss. By the time these symptoms appear, the disease is typically advanced.
Diagnosis usually begins with imaging — a CT scan or PET scan that shows pleural thickening or fluid accumulation. A biopsy confirms the diagnosis, and immunohistochemistry distinguishes mesothelioma from other cancers. The pathology tissue from that biopsy is evidence — it may contain asbestos fibers that can be analyzed by electron microscopy and potentially linked to a talc source.
Treatment typically involves multimodal therapy: surgery (extrapleural pneumonectomy or pleurectomy/decortication) combined with chemotherapy, and in some cases radiation or immunotherapy. The medical costs are extraordinary. The pain and suffering in the final months of life are catastrophic.
The median survival for pleural mesothelioma is twelve to twenty-one months from diagnosis. This is the cruelest number in the entire case — and it is also the clock that governs the urgency of preserving the victim’s testimony and building the case while they are still able to participate.
The Evidence That Proves Your Case — and How Fast It Disappears
Every talc mesothelioma case is built from several categories of evidence. Each category has a clock. Some of those clocks are short.
Pathology tissue and biopsy slides. The tissue from the biopsy that confirmed the mesothelioma diagnosis may contain asbestos fibers. A forensic pathologist can perform fiber analysis using electron microscopy to identify the type and form of asbestos present — and in some cases, link those fibers to a talc source. Hospitals retain tissue blocks per their own policy, but fiber analysis capability degrades over time, and the treating oncologist and pathology expert availability creates a witness-timeline pressure. This evidence must be requested and preserved early.
Medical records. The complete medical file — pathology report, imaging studies, treatment records, medication records, hospital bills — establishes the diagnosis, the course of the disease, and the costs. These records are generally retained by healthcare providers for a period of years, but the full file should be requested immediately. Gaps in the medical record are the defense’s friend.
Product usage history. This is the evidence that connects the disease to Johnson’s Baby Powder specifically. It includes receipts (largely irretrievable for purchases made decades ago), household inventory (old bottles or boxes that may still exist in the home), and — most importantly — witness testimony from family members who can describe decades of use. What brand was used. How often. On whom. For how many years. Family witness testimony must be preserved before memories fade further. If the person who used the product is still alive, their own testimony about their usage habits is irreplaceable — and time-limited, given mesothelioma’s short median survival.
Work and residential history. The defense will argue the mesothelioma came from somewhere else — occupational asbestos exposure, environmental exposure, other products. A complete work and residential history, documented early, preempts this defense. If the patient never worked in an asbestos-heavy industry, never lived near a known asbestos site, and never used other products containing asbestos, the alternative-causation defense collapses. But this history has to be documented before the defense builds its narrative.
Internal J&J corporate records. The internal corporate records documenting asbestos contamination at J&J’s mining and processing sites — lab testing data from 1971 through the early 2000s — have already been produced in prior talc trials. They remain subject to protective orders and ongoing discovery disputes in pending cases. These documents prove the knowledge element of the failure-to-warn claim and establish the punitive damages predicate. Your lawyer does not need to recreate them — but your lawyer does need to be in a case where they can be accessed.
The Lancet retraction documentation. The retraction itself and the accompanying editorial are permanently available as public record. The underlying correspondence between the author and J&J — the draft-sharing and feedback exchanges — requires discovery in pending cases. This evidence is new. It was not available in earlier trials. It is available now.
J&J bankruptcy filings and court rejection orders. These are public court records, permanently available through PACER and bankruptcy court dockets. They demonstrate a pattern of liability avoidance and support the punitive damages narrative of corporate refusal to accept responsibility.
The fastest-dying evidence in a talc mesothelioma case is the victim’s own testimony. Mesothelioma’s median survival of twelve to twenty-one months from diagnosis means the window to preserve what the victim knows — how they used the product, when they started, how often, on whom — is measured in months, not years. If the person who used the product is still alive, preserving their testimony is the single most time-sensitive step in the case.
What J&J’s Lawyers Will Argue — and How Each Defense Is Answered
Johnson & Johnson has a sophisticated, well-funded defense apparatus. The company has tried thousands of these cases and has a developed playbook. Here are the plays you should expect — and the counter to each one.
Play 1: Alternative Causation. J&J will argue the mesothelioma came from somewhere other than its baby powder. Environmental asbestos. Other cosmetic brands. The husband’s automotive work. Occupational exposure. This was exactly the defense J&J ran in the Lozano trial — and the jury rejected every one of these arguments and placed full responsibility on J&J. The counter is a combination of exposure documentation (decades of daily use of a single product), work and residential history (ruling out occupational and environmental asbestos), and expert fiber analysis (linking asbestos fibers in tissue to the talc source). When the exposure history is overwhelming — fifty years of daily use — and the alternative sources are absent, the defense collapses.
Play 2: The Scientific Literature Defense. For decades, J&J relied on a nearly fifty-year-old paper published in The Lancet to argue cosmetic talc does not cause cancer. That paper is now retracted. The Lancet found the author’s undisclosed J&J relationship was a “clear breach of publishing ethics.” The defense’s primary general-causation shield has been destroyed. The counter is direct: the paper the defense relied on was not independent science — it was corporate-influenced literature, and the journal that published it has admitted the breach. Multiple juries have now found causation sufficient without the benefit of this retraction. With it, the defense’s scientific position is weaker than it has ever been.
Play 3: The Bankruptcy Strategy. J&J tried three times to force all talc claims into bankruptcy through the Texas Two-Step, creating subsidiaries to absorb the lawsuits and filing for Chapter 11. Three times a federal judge said no. After the third rejection in March 2025, J&J abandoned the strategy. The bankruptcy freeze is over. The counter is simple: the cases are back in the tort system, and every verdict puts pressure on J&J’s litigation reserves. J&J can no longer try to buy global peace through a single bankruptcy proceeding.
Play 4: Causation Sufficiency Challenges. On appeal, J&J will argue that the plaintiff did not prove its specific product caused this specific cancer — especially given the long latency and multiple potential exposure sources. The counter is the jury’s full-responsibility finding, the decades of daily use, the internal corporate documents showing knowledge of contamination, the Lancet retraction showing manipulation of scientific literature, and the expert testimony linking asbestos fibers in tissue to the talc source.
Play 5: Punitive Damages Ratio Challenges. If the verdict includes a punitive component, J&J will argue on appeal that the punitive award violates the federal due process ratio analysis — the principle that punitive damages must bear a reasonable relationship to compensatory damages. The counter is that California has no statutory cap on punitive damages, that the decades of documented concealment satisfy the malice, oppression, or fraud standard by clear and convincing evidence, and that the due process analysis permits higher ratios when the conduct is especially reprehensible. Concealing asbestos contamination from consumers and regulators for fifty years is about as reprehensible as product liability conduct gets.
What a Talc Mesothelioma Case Is Worth in California
The $32 million Lozano verdict is established. It is on appeal, and the amount may change — but it is a real number returned by a real Los Angeles jury after hearing the full evidence.
For comparable California talc-mesothelioma wrongful death cases with similar exposure duration (fifty-plus years), internal corporate knowledge evidence, and an LA County venue, settlement value typically ranges from $5 million to $15 million, while trial value ranges from $20 million to $50 million or more depending on punitive findings. These are not predictions for your case — they are the range that experienced practitioners see in this specific case type, in this specific venue, with this specific fact pattern.
The comparable verdicts tell a story about venue-driven variance. The $966 million Los Angeles verdict in October 2025 — where the jury affirmatively found malice, oppression, or fraud by clear and convincing evidence — shows what a Los Angeles jury can do when the punitive evidence is strong. The $1.5 billion Baltimore verdict in December 2025, described as the largest single-plaintiff talc verdict ever recorded, shows what a different jurisdiction can produce. The $65.5 million Minnesota verdict and the Philadelphia verdict show that juries across the country are finding for plaintiffs. Each of those is a jury verdict subject to post-trial motions and appeal — we are not telling you these are final, confirmed recoveries.
California remains among the highest-value forums for plaintiffs in pharmaceutical and consumer-product mass torts, and the reasons are structural: strict liability without proof of negligence, no cap on non-economic damages, no cap on punitive damages, and a jury pool that has historically been skeptical of corporate concealment.
The damages in a fatal mesothelioma case fall into several categories:
Wrongful death damages — the losses suffered by the family: loss of financial support, loss of companionship, loss of guidance, loss of consortium, and funeral expenses. California’s wrongful death doctrine allows recovery by statutory beneficiaries for these losses.
Survival damages — the losses the decedent suffered before death: pain and suffering, medical expenses, and lost earnings during the period between injury and death. California’s survival statute allows the estate to recover these damages.
Punitive damages — if the jury finds malice, oppression, or fraud by clear and convincing evidence, California authorizes exemplary damages with no statutory cap, subject only to federal due process ratio analysis. The decades of documented concealment, the failure to report to the FDA, and the Lancet retraction together provide the evidentiary architecture for a substantial punitive award.
A life-care planner builds the cost stream — the medical bills, the treatment costs, the end-of-life care — and a forensic economist reduces it to present value. In a fatal mesothelioma case, the life-care planning elements focus on retrospective medical costs and end-of-life care rather than future care needs, which shifts the damages emphasis to non-economic loss and punitive proportions.
Past results depend on the facts of each case and do not guarantee future outcomes. What we can tell you is that the evidentiary landscape has never been stronger for plaintiffs in talc mesothelioma cases — the Lancet retraction, the end of the bankruptcy strategy, and the cascade of verdicts all point in one direction. A Los Angeles talc mesothelioma lawyer who knows this specific case type, this specific venue, and this specific defendant can evaluate your case honestly and tell you where it falls.
How a Talc Case Is Actually Built
Here is the chronological walk of how a talc mesothelioma case is built — from the first phone call through resolution.
Week one: intake and preservation. The first call triggers the preservation process. Medical records are requested — pathology, imaging, treatment, bills. If the victim is still alive, their testimony is preserved immediately — a sworn statement or deposition that locks in their account of how they used the product, when they started, how often, and on whom. Family members are interviewed about product usage history. Any remaining product containers are photographed and secured. The work and residential history is documented to preempt the alternative-causation defense.
Weeks two through eight: evidence development. The pathology tissue is sent for fiber analysis by a forensic pathologist using electron microscopy. The exposure timeline is built — a year-by-year reconstruction of when Johnson’s Baby Powder was used, how frequently, and on whom. Expert witnesses are identified: a talc-geology and asbestos-mineralogy expert who can explain how asbestos contaminates talc during mining, a forensic pathologist who can perform fiber analysis on tissue samples, a regulatory-history expert who can walk the jury through J&J’s decades of non-reporting to the FDA, and a treating oncologist who can describe the disease and its course.
Months two through six: discovery. The internal J&J corporate records are accessed — the lab testing data, the mining and processing site contamination records, the FDA communications. The Lancet retraction documentation is developed — the retraction itself is public, but the underlying correspondence between the author and J&J requires discovery. Expert reports are prepared. Depositions are taken — of J&J corporate witnesses, of the defense’s experts, of family members who can testify to the product usage history.
Months six through trial: building the number. A life-care planner builds the cost stream. A forensic economist reduces it to present value. The damages model is constructed — medical expenses, pain and suffering, lost earnings, loss of consortium, funeral expenses, and punitive damages if the evidence supports the malice, oppression, or fraud standard. The number at the end is built from all of it — the pathology, the exposure history, the corporate documents, the expert testimony, and the life-care plan.
Trial. In Los Angeles County Superior Court, the case is heard by a jury drawn from one of the largest and most diverse jury pools in the United States — a pool that has historically been skeptical of corporate defendants in concealment cases. The jury hears the internal corporate documents. The jury hears about the Lancet retraction. The jury hears about the fifty years between the first detection of asbestos contamination and the end of global sales. And the jury decides.
This is not a fast process. But the bankruptcy freeze is over, the cases are moving, and the evidentiary landscape has never been stronger.
Your First Steps After a Mesothelioma Diagnosis
If you or someone you love has been diagnosed with mesothelioma after years of using Johnson’s Baby Powder, the steps you take in the first weeks matter — some of them are irreversible.
Step 1: Get the complete medical file. Request the pathology report, the biopsy results, the imaging studies, the treatment plan, and the complete billing records. These documents establish the diagnosis, the course of the disease, and the costs. Do not assume the hospital will keep everything indefinitely — request it now.
Step 2: If the patient is still alive, preserve their testimony. Mesothelioma’s median survival is twelve to twenty-one months from diagnosis. The window to preserve what the victim knows — how they used the product, when they started, how often, on whom — is measured in months. A sworn statement or deposition, arranged through a lawyer, locks in this testimony before the disease progresses. This is the single most time-sensitive step in the entire case.
Step 3: Document the product usage history. Interview family members. What brand of baby powder was used? Johnson’s was the dominant brand for decades — if the family used baby powder, it was almost certainly Johnson’s. How often was it used? Daily? After every bath? On the children? On the spouse? For how many years? Write this down. Photograph any remaining product containers. Old Johnson’s Baby Powder bottles or boxes may still be in the home — they are evidence.
Step 4: Document the work and residential history. The defense will argue the mesothelioma came from somewhere else — occupational asbestos, environmental exposure, other products. A complete work history (every job, every employer, every industry) and residential history (every address, every neighborhood) preempts this defense. If the patient never worked in construction, shipbuilding, auto repair, insulation, or any other asbestos-heavy industry, the alternative-causation defense is weakened.
Step 5: Call a lawyer. The statute of limitations is ticking. California’s two-year statute of limitations for personal injury and wrongful death typically runs from the date of discovery or the date of death, respectively. For talc cases, the discovery rule is critical — the clock may start when you discovered (or should have discovered) the connection between your mesothelioma and your talc use, not when the exposure occurred decades ago. But the discovery rule is not unlimited, and its application to toxic tort cases should be confirmed with an attorney for your specific situation. Do not wait to find out if the clock has already started. Find out now.
Step 6: Do not sign anything. Do not sign anything from Johnson & Johnson, from any claims administrator, from any entity offering to evaluate your claim, or from any insurance company. Do not give a recorded statement to anyone. Do not post about your diagnosis or your product usage on social media. Everything you say can and will be used by the defense.
Step 7: Do not throw anything away. Old product containers, old receipts, old photographs showing baby powder in the home — all of it is evidence. Secure it.
Frequently Asked Questions
Can I sue Johnson & Johnson if I used baby powder and got mesothelioma?
Yes. If you used Johnson’s Baby Powder for years and were diagnosed with mesothelioma, you may have a product liability claim against Johnson & Johnson. The claim is based on strict products liability — the product was contaminated with asbestos, the company knew about the contamination for decades, and it did not warn consumers. A Los Angeles jury has already returned a $32 million verdict on exactly this theory. The deadline to file depends on when you discovered (or should have discovered) the connection between your diagnosis and your talc use — talk to a lawyer to confirm the deadline for your specific situation.
How long do I have to file a talc lawsuit in California?
California’s statute of limitations for personal injury and wrongful death is generally two years. For personal injury, the clock typically starts when you discovered (or should have discovered) your injury and its cause. For wrongful death, the clock typically starts on the date of death. Because mesothelioma has a latency period of twenty to sixty years, the discovery rule is especially important — the clock does not start when you were exposed to the talc decades ago, it starts when you learned the talc caused your cancer. But the discovery rule has limits, and its application varies by case. Do not assume you have plenty of time. Confirm the deadline with an attorney.
What if my family member already died from mesothelioma?
If your family member died from mesothelioma after years of using Johnson’s Baby Powder, you may be able to continue or file a wrongful death lawsuit. In the Lozano case, the mother filed a personal injury lawsuit after her 2023 diagnosis, died in 2024, and her three children continued the case as a wrongful death lawsuit — resulting in the $32 million verdict. California’s wrongful death statute allows statutory beneficiaries (typically spouse, children, domestic partner, and in some cases parents) to recover for loss of financial support, companionship, guidance, and funeral expenses. The wrongful death statute of limitations is generally two years from the date of death.
Is it too late if the exposure happened decades ago?
Not necessarily. Mesothelioma has a latency period of twenty to sixty years — symptoms do not appear until decades after the exposure. California’s discovery rule means the statute of limitations typically starts when you discovered (or should have discovered) the injury and its cause, not when the exposure occurred. If you were just diagnosed with mesothelioma and just learned that talc may have caused it, the clock may have just started. But the discovery rule is not unlimited, and you should confirm the deadline with an attorney immediately.
What evidence do I need for a talc mesothelioma case?
The most important evidence is the pathology tissue from your biopsy — it may contain asbestos fibers that can be analyzed and linked to a talc source. You also need your complete medical records, documentation of your product usage history (family testimony about what brand was used, how often, for how many years), your work and residential history (to rule out other asbestos sources), and any remaining product containers. The internal J&J corporate records showing decades of knowledge about asbestos contamination are accessed through the legal process — your lawyer does not need you to produce those. The Lancet retraction documentation is public record.
How much is my talc mesothelioma case worth?
Case value depends on the specific facts: the duration and intensity of talc exposure, the strength of the alternative-causation defense, the venue, and whether the evidence supports punitive damages. The $32 million Lozano verdict is a real number from a Los Angeles jury. For comparable cases with similar exposure duration and LA County venue, trial values can range from $20 million to $50 million or more, and settlement values typically range from $5 million to $15 million. Comparable verdicts in other jurisdictions include $966 million (Los Angeles), $1.5 billion (Baltimore), and $65.5 million (Minnesota). Past results depend on the facts of each case and do not guarantee future outcomes. An attorney can evaluate your specific case and give you an honest assessment.
What will Johnson & Johnson argue in my case?
J&J’s primary defense is alternative causation — arguing the mesothelioma came from somewhere other than its baby powder (environmental asbestos, other cosmetics, occupational exposure). The Lozano jury rejected every alternative-causation argument. J&J may also challenge the scientific causation — but the Lancet retraction of the defense’s primary scientific paper has significantly weakened this defense. J&J may challenge punitive damages ratios on appeal. A lawyer who knows this specific case type can prepare for and counter each of these defenses.
Do I have to go to court, or can my case settle?
Some talc cases settle and some go to trial. J&J has stated it will litigate each remaining case individually, which means the company is not currently pursuing a global settlement. Whether your case settles depends on the strength of your evidence, the venue, and J&J’s assessment of its trial risk. Every verdict — the $32 million, the $966 million, the $1.5 billion — increases the pressure on J&J to settle remaining claims. But a fair settlement requires a lawyer who is prepared to take the case to trial. Insurance companies and corporate defendants do not pay full value to lawyers who are afraid of the courtroom.
How do I find the right lawyer for a talc mesothelioma case?
Look for a lawyer or firm that specifically handles toxic tort and product liability litigation, has experience with mesothelioma cases, and knows the California legal landscape. Ask whether they have experience with the specific defendant (Johnson & Johnson), whether they understand the Lancet retraction and how to use it, and whether they are prepared to take the case to trial. Ask about the fee structure — it should be contingency, meaning you pay nothing unless you win. Ask whether the first consultation is free. And ask whether they can communicate with you in Spanish if that is your preferred language.
Why People Call Attorney911
We are Attorney911 — The Manginello Law Firm, PLLC. We have been in practice since July 18, 2001 — more than twenty-four years. Our managing partner, Ralph Manginello, has been licensed since November 6, 1998 — more than twenty-seven years. He is a journalist who became a trial lawyer, and he approaches every case the way a reporter approaches a story: find the documents, find the witnesses, find the truth, and then tell it to a jury in language they can feel. He is admitted to the U.S. District Court for the Southern District of Texas, including the Bankruptcy Court, and he takes California cases working with local counsel where the rules require it.
Lupe Peña is our associate attorney. Before he joined this firm, he sat in the rooms where insurance companies and their defense lawyers decided how to deny, delay, and devalue claims — he was an insurance-defense attorney at a national defense firm. He knows how claims are valued, how reserves are set, how IME doctors are selected, how surveillance works, and how delay tactics are deployed. Now he uses that knowledge for injured people. He is fluent in Spanish and conducts full client consultations in Spanish without an interpreter.
We work on contingency. The fee is 33.33% before trial and 40% if the case goes to trial. We do not get paid unless we win your case. The first consultation is free, and our staff is live 24 hours a day, 7 days a week — not an answering service, a person.
If you or someone you love has been diagnosed with mesothelioma after years of using Johnson’s Baby Powder, call us at 1-888-ATTY-911 (1-888-288-9071). We will listen. We will tell you honestly whether we can help. And if we are not the right fit for your case, we will tell you that too.
Hablamos Español.
This page is legal information, not legal advice. Past results depend on the facts of each case and do not guarantee future outcomes. Every case is different. The verdicts and case values discussed here are drawn from public reporting and are presented for context, not as a prediction of what your case will produce. The statute of limitations is real and it is ticking. The evidence is perishable. The person who used the product may not be able to testify forever. The sooner you call, the more we can do.
Call 1-888-ATTY-911. Free consultation. No fee unless we win.